세계의 세포 증식 시장 보고서(2025년)
Cell Expansion Global Market Report 2025
상품코드 : 1821621
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세포 증식 시장 규모는 향후 몇 년 동안 급격한 성장이 예상됩니다. 2029년에는 CAGR 16.4%로 593억 1,000만 달러로 성장할 것입니다. 예측 기간의 성장은 생명공학에 대한 투자 증가, 줄기세포 연구 확대, 임상시험 및 의약품 개발, 맞춤형 의료 수요, 바이오 뱅킹 및 세포 저장소 등에 기인합니다. 예측 기간의 주요 동향으로는 기술 발전, 제품 혁신, 전략적 제휴 등이 있습니다.

향후 5년간 성장률 16.4%라는 예측은 지난번 예측보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 싱가포르와 일본에서 개발된 자동 세포배양 시스템 및 GMP 등급 전개 배지의 가격을 급등시키고, 임상시험을 3-6개월 지연시키는 생산 병목현상을 초래하여 미국의 재생의료를 저해할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

만성질환의 유병률 증가는 향후 세포 증식 시장의 수요를 견인할 것으로 예상됩니다. 만성질환은 관리하거나 통제할 수 있는 경우도 있지만, 대부분 완치할 수 없는 장기적인 질병입니다. 유병률의 증가는 담배 사용, 영양 부족, 운동 부족, 과도한 알코올 섭취 등의 요인으로 인해 발생합니다. 세포 증식은 영양분을 보충하고 배양 성능을 저해할 수 있는 독성 대사 폐기물의 축적을 방지하는 중요한 역할을 합니다. 예를 들어, 2023년 1월 미국 국립의학도서관 산하 국립생물공학정보센터(NCBI)는 2050년까지 최소 한 가지 이상의 만성질환을 앓고 있는 50세 이상 인구가 2020년 7,152만 2,000명에서 1억 4,266만 명으로 99.5% 증가할 것으로 예측했습니다. 그 결과, 만성질환 유병률의 증가는 세포 증식 시장의 성장을 촉진할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Cell expansion is a cellular process employed to generate new cell wall material, with the primary objective of regulating the flexibility of the wall and facilitating its stretching and expansion in a specific area. Essential to this process are cell-wall-associated proteins belonging to the expansion family.

The main categories of cell expansion include mammalian, microbial, and other types. Mammalian cell expansion involves the cultivation of cells derived from mammals, conducted through the in vitro cultivation of cells in flasks or bioreactors. The products associated with mammalian cell expansion encompass consumables, reagents, media, serums, disposables, and instruments. These products find application in various fields such as biopharmaceuticals, tissue culture and engineering, vaccine production, drug development, gene therapy, cancer research, stem cell research, and others. The end-users of mammalian cell expansion products include biopharmaceutical and biotechnology companies, research institutes, cell banks, and other relevant entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cell expansion market research report is one of a series of new reports from The Business Research Company that provides cell expansion market statistics, including cell expansion industry global market size, regional shares, competitors with a cell expansion market share, detailed cell expansion market segments, market trends and opportunities, and any further data you may need to thrive in the cell expansion industry. This cell expansion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell expansion market size has grown rapidly in recent years. It will grow from $28.11 billion in 2024 to $32.31 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to public awareness and acceptance, cell-based research applications, rising demand for cell-based therapies, biopharmaceutical industry growth, regenerative medicine advancements.

The cell expansion market size is expected to see rapid growth in the next few years. It will grow to $59.31 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to rising investments in biotechnology, expanding stem cell research, clinical trials and drug development, demand for personalized medicine, biobanking and cell repositories. Major trends in the forecast period include technological advancements, product innovations, strategic collaborations.

The forecast of 16.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. regenerative medicine by inflating prices of automated cell culture systems and GMP-grade expansion media developed in Singapore and Japan, resulting in production bottlenecks that delay clinical trials by 3-6 months. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is anticipated to drive the demand for the cell expansion market in the future. Chronic diseases are long-lasting conditions that often cannot be cured, although they can sometimes be managed or controlled. Their increasing prevalence is attributed to factors such as tobacco use, poor nutrition, physical inactivity, and excessive alcohol consumption. Cell expansion plays a crucial role in replenishing nutrients and preventing the buildup of toxic metabolic waste products that could hinder culture performance. For instance, in January 2023, the National Center for Biotechnology Information (NCBI), part of the US National Library of Medicine, projected that by 2050, the number of individuals aged 50 and older with at least one chronic illness will rise by 99.5%, increasing from 71.522 million in 2020 to 142.66 million. Consequently, the growing incidence of chronic diseases is expected to boost the growth of the cell expansion market.

The growth of the cell expansion market is expected to be propelled by increasing government funding for research and development. Government funding plays a crucial role in fostering innovation, advancing cell-based therapies, and accelerating progress in regenerative medicine. An illustrative example is the National Cancer Institute, a US-based government agency, which received a budget of $7.3 billion in fiscal year 2023 from the United States Congress, marking a $408 million increase from 2022. This substantial increase in government funding for research and development is a driving force behind the growth of the cell expansion market.

Leading companies in the cell expansion market are focusing on advancements in bioprocessing technologies, such as automated 3D bioreactor systems, to improve the efficiency and scalability of cell production for therapeutic purposes. PluriCDMO specializes in large-scale, automated manufacturing of cell therapies utilizing a proprietary 3D bioreactor system, ensuring consistent, high-quality production from early development to clinical trials. For example, in January 2024, Pluristem Therapeutics Inc., a biotechnology company based in Israel, launched a new division called PluriCDMO that will provide cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). This new division features a 47,000-square-foot good manufacturing practice (GMP) facility dedicated to cell therapy production. Through PluriCDMO, the company will offer services ranging from early preclinical development to late-stage clinical trials and commercialization.

Major companies in the cell expansion market are intensifying their focus on introducing advanced bioprocessing platforms, such as the Quantum Flex Cell Expansion System, to gain a competitive edge. The Quantum Flex Cell Expansion System, launched by Terumo Blood and Cell Technologies in June 2023, is designed for scalable and flexible expansion of cell therapies, providing efficient and controlled manufacturing capabilities for cell-based medical treatments. This system supports the expansion of various applications, including suspension and adherent cells, viral vectors, and exosome production, offering the necessary flexibility, scalability, and connectivity to support the growth of cell therapies.

In a strategic move, Sartorius AG, a Germany-based pharmaceutical company, acquired Polyplus-Transfection SA for $2.36 billion in March 2023. This acquisition positions Sartorius AG to strengthen its supply of cell and gene therapy solutions, expanding its portfolio for gene therapies and gene-modified cell therapies. Polyplus-Transfection SA, based in France, is a biotechnology company supporting gene and cell therapy, biologics manufacturing, and life science research.

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd., Worthington Industries Inc.

North America was the largest region in the cell expansion market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell expansion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell expansion market includes revenues earned by entities by providing bioreactors and automated cell expansion systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Expansion Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell expansion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cell expansion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell expansion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Cell Expansion Market Characteristics

3. Cell Expansion Market Trends And Strategies

4. Cell Expansion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cell Expansion Growth Analysis And Strategic Analysis Framework

6. Cell Expansion Market Segmentation

7. Cell Expansion Market Regional And Country Analysis

8. Asia-Pacific Cell Expansion Market

9. China Cell Expansion Market

10. India Cell Expansion Market

11. Japan Cell Expansion Market

12. Australia Cell Expansion Market

13. Indonesia Cell Expansion Market

14. South Korea Cell Expansion Market

15. Western Europe Cell Expansion Market

16. UK Cell Expansion Market

17. Germany Cell Expansion Market

18. France Cell Expansion Market

19. Italy Cell Expansion Market

20. Spain Cell Expansion Market

21. Eastern Europe Cell Expansion Market

22. Russia Cell Expansion Market

23. North America Cell Expansion Market

24. USA Cell Expansion Market

25. Canada Cell Expansion Market

26. South America Cell Expansion Market

27. Brazil Cell Expansion Market

28. Middle East Cell Expansion Market

29. Africa Cell Expansion Market

30. Cell Expansion Market Competitive Landscape And Company Profiles

31. Cell Expansion Market Other Major And Innovative Companies

32. Global Cell Expansion Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Expansion Market

34. Recent Developments In The Cell Expansion Market

35. Cell Expansion Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기